Bain Capital Is in Talks to Buy PCI Pharma at a $10 Billion Valuation

Bain Capital is in talks to buy PCI Pharma Services, people with knowledge of the matter said, in a deal that would rank among the year’s largest private equity takeovers.

The buyout firm is in discussions with PCI’s backers, Kohlberg & Co., Mubadala Investment Co. and Partners Group Holding AG, about a deal for a majority stake that could value the Philadelphia-based drug services provider at more than $10 billion, including debt, the people said.